难治性FSGS治疗策略 FSGS:定义 什么是FSGS?FSGS不是一种疾病，而是一种不具备任何预后判断价值的组织学改变 FSGS可以统称为肾小球足突病变 免疫学源性足突病变病毒性足突病变中毒性足突病变遗传性足突病变 难治性FSGS治疗策略 NephrolDialTransplant2004;19:2437–2444 FSGS:组织学特征 光镜下 局灶节段性肾小球...
7、4020 0 12 26 52 78 104环孢素组完全缓解率环孢素组部分缓解率安慰剂组部分缓解率缓解率%时间(周)环孢素有效保护远期肾功能Ccr降低50%的患者比例%时间(周)*P0.0552%25%*Kidney International.1999;56:22202226研究结论Kidney International.1999;56:22202226环孢素治疗FSGS CARI指南The CARI Guidelines Caring...
环孢素治疗FSGS CARI指南 剂量 大部分研究剂量为5mg/kg/天,维持谷浓度100–200 mg/mL 疗程The CARI Guidelines – Caring for Australasians with Renal Impairment 2005Focal segmental glomerulosclerosis: use of cyclosporin A 疗程 最小剂量应当至少维持2年 中断治疗或减量后常常复发 ...
The KDIGO Guidelines on Glomerulonephritis: reading between the guidelines: Treatment of FSGS After a description of the principles of the radiation treatment of food, the main applications in food industry are listed. Then, the status on possible i... J Radhakrishnan - 《Journal De Pharmacie De...
环孢素治疗FSGS CARI指南 剂量 大部分研究剂量为5mg/kg/天,维持谷浓度100–200 mg/mL 疗程 最小剂量应当至少维持2年 中断治疗或减量后常常复发 环孢素治疗后完全缓解1年以上患者,如果环孢素逐渐减量至停用,而不是突然停药,更有可能维持病情缓解 The CARI Guidelines – Caring for Australasians with Renal ...
The CARI Guidelines – Caring for Australasians with Renal Impairment The CARI Guidelines The CARI Guidelines –– Caring for Australasians with Renal Impairment 2005 Caring for Australasians with Renal Impairment 2005 Focal segmental glomerulosclerosis: use of cyclosporin A Focal segmental glomerulosclerosis...
The CARI Guidelines – Caring for Australasians with Renal Impairment The CARI Guidelines The CARI Guidelines –– Caring for Australasians with Renal Impairment 2005 Caring for Australasians with Renal Impairment 2005 Focal segmental glomerulosclerosis: use of cyclosporin A Focal segmental glomerulosclerosis...
FSGS recurrence is a challenging medical condition, not only because there is no recognised predictor of FSGS recurrence in the allograft, but also because there are no available international guidelines for treatment of this condition which add more mystery to the dilemma created by this vague ...
7.Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. (2020). KDIGO 2020 Clinical Practice Guidelines for Glomerulonephritis. Kidney International, 98(4), 869-911.
7.Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. (2020). KDIGO 2020 Clinical Practice Guidelines for Glomerulonephritis. Kidney International, 98(4), 869-911.